A norovirus vaccine could be on the horizon as cases rise
1. Moderna is testing a norovirus vaccine with a large trial underway. 2. Norovirus cases have doubled this January compared to last year. 3. Moderna's vaccine aims to help vulnerable populations, not complete prevention. 4. Results from the trial are anticipated between late 2024 and 2026. 5. Investor interest hinges on vaccine effectiveness and market viability.